Purchase Order 36C26324P0238
Award Date
12/14/23
Potential Completion Date
1/13/24
Potential Value
$17K
Federal Agency
Veterans Integrated Service Network 23
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Omaha, NE 68105, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs' Veterans Health Administration awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business, to provide Miltefosine drug with a potential value of $149,950.00. The order, placed under the VHA's Veterans Integrated Service Network 23, supports the agency's mission to deliver healthcare services to veterans by ensuring access to this specialized pharmaceutical product needed for treatment. Profounda has previously...
The U.S. Department of Veterans Affairs (VA) has awarded a $49,950 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract is for the emergency delivery of 84 tablets of Impavido (Miltefosine) in three packages of 28, to the VA's Oklahoma City VA Medical Center (OKCVAMC) Pharmacy. This purchase order is part of a larger Blanket Purchase Agreement (BPA) valued at $1,127,000 that Profounda Inc. holds...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer, for the delivery of Emergency Patient Profounda Miltefosine Dose Packs. The $16,650 contract has an April 30, 2024 completion date and supports the VHA's mission to provide healthcare services to veterans by ensuring access to this specialty pharmaceutical product. Profounda has previously received...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $144,000.00 firm fixed-price purchase order is for the delivery of Impavido/Miltefosine, a specialized medication used to treat leishmaniasis and other drug-resistant infections in veterans. Profounda Inc. has received numerous similar purchase orders from various Veterans Integrated...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business. The $49,950.00 contract is for the delivery of Profounda's Impavido/Miltefosine pharmaceutical product to the VA Sunshine Healthcare Network (VISN 20) in Orlando, Florida. Impavido/Miltefosine is used to treat leishmaniasis and other drug-resistant infections in veterans. This award is the latest in a...
The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The order calls for Emergent Devices to supply pharmaceutical items to meet the clinical needs of VA's Veterans Integrated Service Network 12, located in Wayne, Pennsylvania, with performance from December 4-11, 2020. No subcontractors or set aside designations were identified. This order...
This $162,393.60 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 15 to Core Trading Co, a minority-owned, veteran-owned, service-disabled veteran-owned small business located in Chesapeake, Virginia. The contract is for the delivery of six pharmaceutical products to the Chelmsford VA Center facility, including vaginal moisturizer gel, multivitamin/ophthalmology chewable tablets, psyllium powder packets, wound therapy solution,...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 awarded a $10,891.30 firm fixed price delivery order to Fennec Pharmaceuticals, Inc. on January 4, 2024. This order, which had no set-aside designation, is for the STRATUS TURN SYSTEM to support health programs for veterans in the Biloxi, Mississippi area. The period of performance ends on May 4, 2024. Fennec Pharmaceuticals, Inc. is a foreign-owned, for-profit...